Loading the company…
Loading the company…
In the last ten years FDA made 4 decisions for Bausch And Lomb (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (2). The latest was on 2026-05-15.
| Family | Decisions on record |
|---|---|
| Cataract & MIGS | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-05-15 | 510(k) | K261264 | Stellaris Elite vision enhancement system; Posterior and Combined Procedure Pack(s): 23 ga. Posterior Elite Pack (SE5423); 23 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5423B); 25 ga. Posterior Elite Pack (SE5425); 25 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5425B); 27 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5427B); 23 ga. Bi-Blade+ Vitreous Cutter Posterior Stellaris Elite Pack (SE5423BB+); 25 ga. Bi-Blade+ |
| 2026-03-25 | 510(k) | K252052 | Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E) |
| 2024-07-26 | 510(k) | K240169 |
| Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455) |
| 2024-02-26 | 510(k) | K232084 | Stellaris Elite vision enhancement system |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Bausch And Lomb.